Drugs / SLITone Dermatophagoides mix
last change Feb 2009 re-read 2 minutes ago

SLITone Dermatophagoides mix

Other / unclassified

Developed for
allergic disease

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT00633919 Comparator Jul 2006 → Dec 2008 allergic disease ALK-Abelló A/S Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SLITone Dermatophagoides mix “Sublingual immunotherapy with SLITone Dermatophagoides mix (200 STU) once daily for 2 years” NCT00633919
Modality Other / unclassified “specific immunotherapy with SLITone Dermatophagoides mix” NCT00633919